ES2056194T3 - Compuestos tetraciclicos antidepresivos. - Google Patents

Compuestos tetraciclicos antidepresivos.

Info

Publication number
ES2056194T3
ES2056194T3 ES89202105T ES89202105T ES2056194T3 ES 2056194 T3 ES2056194 T3 ES 2056194T3 ES 89202105 T ES89202105 T ES 89202105T ES 89202105 T ES89202105 T ES 89202105T ES 2056194 T3 ES2056194 T3 ES 2056194T3
Authority
ES
Spain
Prior art keywords
different
compounds
tetraciclic
antidepressive
substitutes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89202105T
Other languages
English (en)
Inventor
Johannes Hubertus Wieringa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of ES2056194T3 publication Critical patent/ES2056194T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA INVENCION SE REFIERE A NUEVOS COMPUESTOS TETRACICLICOS CON ACCION ANTIDEPRESORA, SIN EFECTS SECUNDARIOS NEUROLEPTICOS O SEDANTES, DE FORMULA GENERAL (I), Y SUS DERIVADOS FUNCIONALES, DONDE R1 REPRESENTA 1 O 2 SUSTITUYENTES IDENTICOS O DIFERENTES H, OH, HALOGENO, ALQUILO C1-C4 O ALCOXI C1-C4; R2 REPRESENTA 1 O 2 SUSTITUYENTES DIFRENTES QUE TIENEN EL MISMO SIGNIFICADO QUE R1; R3 Y R4 SON 2 SUSTITUYENYES QUE ESTAN EN CONFIGURACION CIS Y UNO DE LOS CUALES ES H Y EL OTRO OH; R5 ES H O ALQUILO C1-C4; X ES O O S; N ES 0 O 1.
ES89202105T 1988-08-26 1989-08-17 Compuestos tetraciclicos antidepresivos. Expired - Lifetime ES2056194T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8802109 1988-08-26

Publications (1)

Publication Number Publication Date
ES2056194T3 true ES2056194T3 (es) 1994-10-01

Family

ID=19852805

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89202105T Expired - Lifetime ES2056194T3 (es) 1988-08-26 1989-08-17 Compuestos tetraciclicos antidepresivos.

Country Status (16)

Country Link
US (1) US4977158A (es)
EP (1) EP0357126B1 (es)
JP (1) JP2521157B2 (es)
KR (1) KR900003177A (es)
AT (1) ATE104981T1 (es)
AU (1) AU618392B2 (es)
CA (1) CA1325807C (es)
DE (1) DE68914917T2 (es)
DK (1) DK415789A (es)
ES (1) ES2056194T3 (es)
FI (1) FI91638C (es)
IE (1) IE62754B1 (es)
MX (1) MX9203809A (es)
NZ (1) NZ230128A (es)
PT (1) PT91555B (es)
ZA (1) ZA895623B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT726265E (pt) * 1995-02-08 2001-12-28 Novartis Ag 10-amino-alifatil-dibenzo¬b,f| oxepinas com accao antineurodegenerativa
AU2418499A (en) * 1997-12-19 1999-07-12 Akzo Nobel N.V. Org-5222 in the treatment of depression
HRP20020305A8 (en) 2002-04-10 2009-03-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
HRP20020440B1 (en) 2002-05-21 2008-02-29 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
HRP20020452A2 (en) 2002-05-23 2004-02-29 Pliva D D 1,2-diaza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediates for preparation thereof
HRP20030956A2 (en) * 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1,2-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANU
JP5245428B2 (ja) * 2007-07-06 2013-07-24 住友化学株式会社 トランス−ジベンゾオキセノピロール化合物の製造方法およびその中間体
BRPI0908098A2 (pt) * 2008-02-19 2015-08-18 Adolor Corp Beloxepina, composição, métodos para tratar dor em um mamífero, para inibir a recaptação de ne, para antagonizar um receptor de 5ht2 e para tratar um distúrbio em um paciente que é responsivo ao tratamento com um composto nri e com um composto antagonista de 5ht2
US20090233958A1 (en) * 2008-02-19 2009-09-17 Adolor Corporation (+)-beloxepin and methods for its synthesis and use
US20090233957A1 (en) * 2008-02-19 2009-09-17 Adolor Corporation (-)-beloxepin and methods for its synthesis and use
US20090233959A1 (en) * 2008-02-19 2009-09-17 Adolor Corporation Beloxepin and analogs for the treatment of pain

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4158059A (en) * 1976-05-24 1979-06-12 Akzona Incorporated Tension reducing 2,3,4,4a,9,136-hexahydro-dibenz[1,2;5,6]cyclohepta[3,4-c]py
US4271179A (en) * 1976-05-24 1981-06-02 Akzona Incorporated 1,2,3,3a,8,12b-Hexahydro-dibenzo[1,2;5,6]cyclohepta[3,4-C]pyrroles and pharmaceutical use thereof
NL7605526A (nl) * 1976-05-24 1977-11-28 Akzo Nv Nieuwe tetracyclische derivaten.
US4271177A (en) * 1976-05-24 1981-06-02 Akzona Incorporated 2,3,3a,12b-Tetrahydro-1H-dibenzo[2,3;6,7]thiepino[4,5-c]pyrroles and pharmaceutical use thereof
WO1988000049A1 (fr) * 1986-06-26 1988-01-14 Kyowa Hakko Kogyo Co., Ltd. Agent antiarythmique

Also Published As

Publication number Publication date
DK415789D0 (da) 1989-08-23
DE68914917T2 (de) 1994-08-11
JPH02111776A (ja) 1990-04-24
IE892363L (en) 1990-02-26
CA1325807C (en) 1994-01-04
FI893901L (fi) 1990-02-27
DK415789A (da) 1990-02-27
DE68914917D1 (de) 1994-06-01
US4977158A (en) 1990-12-11
EP0357126A1 (en) 1990-03-07
PT91555B (pt) 1995-05-04
FI91638C (fi) 1994-07-25
PT91555A (pt) 1990-03-08
FI893901A0 (fi) 1989-08-18
JP2521157B2 (ja) 1996-07-31
ATE104981T1 (de) 1994-05-15
AU618392B2 (en) 1991-12-19
FI91638B (fi) 1994-04-15
NZ230128A (en) 1990-10-26
ZA895623B (en) 1990-05-30
EP0357126B1 (en) 1994-04-27
AU4002289A (en) 1990-03-01
KR900003177A (ko) 1990-03-23
MX9203809A (es) 1992-07-01
IE62754B1 (en) 1995-02-22

Similar Documents

Publication Publication Date Title
ES2054725T3 (es) Heteroaromatos anulares de cinco miembros de p-fenoxi-fenoximetilo.
ES2075163T3 (es) Uso de bis(3,4-dialquilbenciliden)sorbitol-acetales y de composiciones que los contienen.
ES2083464T3 (es) Compuestos heterociclicos.
ES2053778T3 (es) Procedimiento para la obtencion de derivados del tiazol.
ES2136209T3 (es) Nuevos nitronilfenoles estericamente impedidos utiles como captadores de radicales libres.
ES2056194T3 (es) Compuestos tetraciclicos antidepresivos.
ES2062395T3 (es) Nuevos compuestos de bencimidazol y su uso.
ES2002254T3 (es) Nuevos 5-alcoxi-2,4-diamino-alquilbenzenos asi como tintes para el cabello con 5-alcoxi-2,4-diamino-alquil-benzenos.
ES2063153T3 (es) Amino-4 quinoleinas y naftiridinas, su procedimiento de preparacion y su aplicacion como medicamentos.
ES2040879T3 (es) Procedimiento de preparacion de derivados pirimidinilaminicos de piperidina.
AR245755A1 (es) Compuestos azocolorantes y procedimiento para su obtencion.
ES8705408A1 (es) Un procedimiento para preparar un derivado de 1,5-benzotiazepina.
ES2084015T3 (es) Derivados de 2-aminopirimidina-4-carboxamida, su preparacion y su aplicacion en terapeutica.
ES2062758T3 (es) Nuevos analogos de vitamina d.
ES2056153T3 (es) Expectorante que comprende un derivado hidroxialquilcisteina.
ES2084792T3 (es) Derivados de hexahidroazepinas, un procedimiento para su preparacion y composiciones.
ES2055867T3 (es) Derivados de dibenzotiazepina utiles como agentes antiespasmodicos.
ES2080859T3 (es) Alfa-(alquilciclohexiloxi)-beta-alcanoles y composiciones de perfume que contienen los mismos.
ES2103161B1 (es) Derivados de cicloheptimidazol, metodo de fabricacion de los mismos y agentes terapeuticos que contienen estos compuestos.
ES2053527T3 (es) Derivados de alquilendiamina.
ES2052526T3 (es) Derivados de pirimidina, su preparacion y medicamentos que contienen estos derivados.
ES2038708T3 (es) Metodo para producir compuestos de benzotiepino(5,4-c)piridazina.
ES488901A1 (es) Procedimiento de preparacion de nuevos derivados de benzoil-2 glicilanilidas substituidas
ES2059396T3 (es) Derivados de indeno y metodos.
ES8802489A1 (es) Procedimiento para la obtencion de benzamidas

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 357126

Country of ref document: ES